Sonrotoclax (Beqalzi) indicated for relapsed or refractory mantle cell lymphoma ...

Adding vamikibart to VEGF inhibition improved visual acuity and retinal anatomy ...

On May 15, 2026, Leerink raised the firm’s price target on BeOne Medicines AG (NASDAQ:ONC) to $367 from $364 while ...

When researchers use an inhibitor to block a kinase’s activity, they generally expect to see less of the downstream effects of that kinase. So when neuroscientists observed the opposite using a new ...

Consistent adherence to sodium-glucose cotransporter 2 (SGLT2) inhibitors in individuals with type 2 diabetes reduces the risk of hospitalization, supporting targeted interventions to improve ...

FDA has granted accelerated approval to sonrotoclax (BEQALZI) for adults with relapsed or refractory mantle cell lymphoma ...

The study, published in Nature Biotechnology, highlights the role of Chemistry42 and its submodules in supporting drug candidate design and optimization. The research underscores the potential of ...

Share on Pinterest Scientists are studying treatments to reduce inflammation in Crohn’s disease and ulcerative colitis. Tom Werner/Getty Images Inflammatory bowel disease is a term that includes Crohn ...

Deal gives Vyome entry into the fast-growing market for next-generation autoimmune and inflammatory disease drugs ...

An illustration shows the structure of an inhibitor bound to the active site of membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase. An inhibitor bound to the active site of ...